Foghorn Therapeutics CEO Adrian Gottschalk's 2023 pay falls 54% to $2.5M
Foghorn Therapeutics reports 2023 executive compensation
By ExecPay News
Published: May 3, 2024
Foghorn Therapeutics reported fiscal year 2023 executive compensation information on May 3, 2024.
In 2023, three executives at Foghorn Therapeutics received on average a compensation package of $1.8M, a 51% decrease compared to previous year.
Average pay of disclosed executives at Foghorn Therapeutics
Adrian Gottschalk, Chief Executive Officer, received $2.5M in total, which decreased by 54% compared to 2022. 69% of Gottschalk's compensation, or $1.7M, was in option awards. Gottschalk also received $203K in non-equity incentive plan, $579K in salary, as well as $3K in other compensation.
Alfonso Quintás-Cardama, Chief Medical Officer, received a compensation package of $1.8M. 84% of the compensation package, or $1.5M, was in option awards.
Steven Bellon, Chief Scientific Officer, earned $1.2M in 2023, a 45% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on May 3, 2024.